ProfileGDS5822 / ILMN_2617090
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 72% 68% 66% 73% 64% 79% 70% 65% 59% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 156.572
GSM1276600PDAC Late Ablation Control 246.568
GSM1276601PDAC Late Ablation Control 351.866
GSM1276602PDAC Late Ablation 167.173
GSM1276603PDAC Late Ablation 237.764
GSM1276604PDAC Late Ablation 3134.479
GSM1303940PDAC Late Ablation_anti-CTLA4 147.970
GSM1303941PDAC Late Ablation_anti-CTLA4 248.165
GSM1303942PDAC Late Ablation_anti-CTLA4 336.159